Published in Anal Bioanal Chem on December 18, 2014
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection. Mol Neurodegener (2015) 0.79
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells. Oncotarget (2016) 0.75
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. Parkinsons Dis (2016) 0.75
Inhibition of FAAH confers increased stem cell migration via PPARα. J Lipid Res (2015) 0.75
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations. Int J Mol Sci (2017) 0.75
The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf (2004) 1.57
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst (2007) 1.23
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem Pharmacol (2009) 1.07
Antitumorigenic effects of cannabinoids beyond apoptosis. J Pharmacol Exp Ther (2009) 1.00
Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendations. Ann Rheum Dis (2011) 0.93
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J (2011) 0.92
COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther (2012) 0.89
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Clin Pharmacol Ther (2003) 0.88
Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2003) 0.88
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther (2005) 0.88
The discovery and development of antiinflammatory drugs. Arthritis Rheum (2004) 0.88
Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases. Biochem Biophys Res Commun (2005) 0.86
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm Res (2010) 0.86
R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. Pharm Res (2008) 0.83
Using pharmacokinetic principles to optimize pain therapy. Nat Rev Rheumatol (2010) 0.83
Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2006) 0.82
Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Mol Pharmacol (2003) 0.80
Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib. J Lipid Res (2013) 0.80
Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells. Biochem Pharmacol (2010) 0.79
The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2. Rheumatol Int (2004) 0.78
Aspirin and acetaminophen: should they be available over the counter? Curr Rheumatol Rep (2009) 0.77
Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2005) 0.76
Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis. ChemMedChem (2010) 0.76
Impact of enhanced external counterpulsation on peripheral circulation. Angiology (2007) 0.75
A validated high-performance liquid chromatographic assay for determination of lumiracoxib in human plasma. Biomed Chromatogr (2006) 0.75
[Self-medication of headaches]. Med Monatsschr Pharm (2015) 0.75
A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma. Biomed Chromatogr (2005) 0.75
R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells. Pharm Res (2006) 0.75
[Epidemiology, pathophysiology, and symptoms of headaches]. Med Monatsschr Pharm (2015) 0.75